| JXHL2300324 | 布地格福吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs(2.4) | Import Drug Application | 2023-12-23 | | | | | view |
| JYHB2200287 | 布地格福吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs(2.3) | Supplementary Application | 2022-06-09 | | | | | view |
| JYHB2200075 | 布地格福吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs(2.3) | Supplementary Application | 2022-02-11 | | | | | view |
| JYHB2200286 | 布地格福吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs(2.3) | Supplementary Application | 2022-06-09 | | | | | view |
| JYHZ2400110 | 布地格福吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs(2.3) | License Renew | 2024-05-09 | | | | | view |
| JYHB2200076 | 布地格福吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs(2.3) | Supplementary Application | 2022-02-11 | | | | | view |
| JXHL2400013 | 布地格福吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs(2.4) | Import Drug Application | 2024-01-19 | | | | | view |
| JXHL1500153 | PT010 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs | Import Drug Application | 2015-07-10 | Pearl Therapeutics, Inc. | Pearl Therapeutics Inc | Certificate Issued | 2016-06-08 | view |
| JXHL1500190 | PT010 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs | Import Drug Application | 2015-07-28 | Pearl Therapeutics, Inc. | Pearl Therapeutics Inc | Certificate Issued | 2016-06-08 | view |
| JXHL1500191 | PT010 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs | Import Drug Application | 2015-07-27 | Pearl Therapeutics, Inc. | Pearl Therapeutics Inc | Certificate Issued | 2016-06-08 | view |
| JXHL1600010 | PT010 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs | Import Drug Application | 2016-02-16 | Pearl Therapeutics, Inc. | Pearl Therapeutics Inc | Certificate Issued | 2016-11-24 | view |
| JYHB1900538 | 布地奈德格隆溴铵福莫特罗吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs | Supplementary Application | 2019-05-15 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2019-12-19 | view |
| JXHS1800033 | 布地奈德格隆溴铵福莫特罗吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs(2.3) | Import Drug Application | 2018-09-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-12-19 | view |
| JXHS1800035 | 布地奈德格隆溴铵福莫特罗吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs(2.3) | Import Drug Application | 2018-09-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-12-20 | view |
| JXHS1800034 | 布地奈德格隆溴铵福莫特罗吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs(2.3) | Import Drug Application | 2018-09-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-12-20 | view |
| JYHB1900539 | 布地奈德格隆溴铵福莫特罗吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs | Supplementary Application | 2019-05-16 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2019-12-20 | view |
| JYHB1900540 | 布地奈德格隆溴铵福莫特罗吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs | Supplementary Application | 2019-05-15 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2019-12-20 | view |
| JYHB2000071 | 布地格福吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs(2.3) | Supplementary Application | 2020-01-19 | AstraZeneca AB | AstraZeneca AB | Filed | 2020-02-07 | view |
| JYHB2000070 | 布地格福吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs(2.3) | Supplementary Application | 2020-01-19 | AstraZeneca AB | AstraZeneca AB | Filed | 2020-02-07 | view |
| JYHB2000630 | 布地格福吸入气雾剂 | budesonide;formoterol fumarate;glycopyrronium bromide | Aerosol | Chemical Drugs(2.3) | Supplementary Application | 2020-06-06 | AstraZeneca AB | AstraZeneca AB | In Review | 2020-06-05 | view |
